In yet another instance of deteriorating industrial relations in Haryana, workers in a medical equipment manufacturing company called Eastern Medikit in Gurgaon alleged the firm’s management had left the plant open with no electricity and water supply for over two months.
Industry Experts, Medical Practioners, Consultants and Policy Makers Will Gather To Address At Asia's Biggest 5th Annual Pharmaceutical Leadership Summit and Business Leadership Awards 2012 in Mumbai.
Dr B Arvind Shah, MD and CEO of Arvind Remedies Ltd, a fast-growing pharmaceutical Company, was felicitated with the ‘Samaj Rathna’ Award.
Amra Remedies Ltd., the emerging pharmaceutical and healthcare company, today launched a unique Toilet Seat Sanitiser Spray named elavO.
Drug Technical Advisory Board (DTAB) holds a meeting on July 24 under new DCGI. This is the first meeting one after the present Drug Controller General of India (DCGI) which Dr G N Singh took over a few months ago, with a slew of issues on the platter for discussion, says a Pharmabiz report.
Delhi became the first state in the country to provide a life-long financial assistance HIV/AIDS patient, noted the report.
Seven pharmaceutical companies and four research institutions have joined hands to research in order to find new treatments for tuberculosis.
Government of India has postponed the application by pharma major Pfizer to bring in foreign equity in a company.
An inter-ministerial group set up to frame rules on FDI (foreign direct investment) for brownfield proposals in the pharma sector has decided to do away with the mandatory transfer of technology by the foreign investor to the target company.
Wockhardt's improved business generates optimism though nutrition arm still a concern. There are enough people who do the math with data from drug-maker Wockhardt and say the company is well on its way out of the woods, says a BL report.
Natco Pharma said it will fully investigate all available options for appeal once the Court's full opinion becomes available.
The Rajasthan Government today claimed over 4.4 crore patients have benefited from its free generic medicines scheme so far since its launch last year.
The European Medicines Agency (EMA) has recommended restricting the use of Tolperisone, a muscle relaxant authorised to treat a variety of different conditions, including spasticity due to neurological disorders and muscle spasms associated with diseases of the spine and large joints in several European Union countries since the 1960s.
The Indian generic drug industry is generally receptive to the proposed US law on medicine even though it seeks to enhance US-FDA inspection of the manufacturing facilities globally for a fee.
The Ayurveda, Siddha and Unani (ASU) industry has strongly opposed the provisions enlisted in the draft rule 161 issued by the Department of Ayush which requires all the ASU manufacturers to provide additional details on the labels of Indian Systems of Medicine (ISM) covered under the patent or proprietary ASU therapies.
